New Primary Malignancy Masquerading as Metastatic Prostate Adenocarcinoma by Ellen A. Szwed, Sarunas Sliesoraitis, Thu-Cuc Nguyen, Minh-Nguyet Nguyen, Jan S. Moreb, Robert A. Zlotecki, Paul L. Crispen, Nam H. Dang, Long H. Dang

“…In the management of patients with prostate cancer, the development of new radiographic findings can mimic progression of the disease, thereby triggering changes in treatment. …”
Get full text

Generalized Lymphadenopathy: Unusual Presentation of Prostate Adenocarcinoma by Bulent Cetin, Zeynep Cetin, Suleyman Buyukberber, Ipek Isık Gonul, Ilgin Sahiner, Ugur Coskun, Mustafa Benekli

“…We emphasize that a suspicion of prostate cancer in men with adenocarcinoma of undetermined origin is important for an adequate diagnostic and therapeutic approach.…”
Get full text

Androgen Receptor Regulates Transcription of the ZEB1 Transcription Factor by Bynthia M. Anose, Michel M. Sanders

“…Because it is induced by estrogen and progesterone and is high in prostate cancer, we investigated whether tcf8, which encodes ZEB1, is regulated by androgen. …”
Get full text

Cavernous Nerve Injury Resulted Erectile Dysfunction and Regeneration by Nan Jiang, Cheng Wu, Xunrong Zhou, Guanghua Zhai, Jian Wu

“…Recent studies have found that cavernous nerve injury (CNI) during prostate cancer surgery and other pelvic surgery results in medically induced CNIED in more than 80% of patients. …”
Get full text

Salvage Brachytherapy for Castration-Resistant and External Beam Radiotherapy-Resistant Local Recurrence 17 Years after Radical Prostatectomy by Shogo Hosogoe, Osamu Soma, Teppei Matsumoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama, Masahiko Aoki

“…A 47-year-old Japanese man was diagnosed with prostate cancer in February 1995 (Initial PSA 77.2 ng/mL, GS3 + 4, cT3N0M0). …”
Get full text

Synthesis and Characterization of Theranostic Poly(HPMA)-c(RGDyK)-DOTA-Cu Copolymer Targeting Tumor Angiogenesis: Tumor Localization Visualized by Positron Emission Tomography by Jianchao Yuan, Haiyuan Zhang, Harpreet Kaur, David Oupicky, Fangyu Peng

“…Tumor localization of the poly(HPMA)-c(RGDyK)-DOTA- 64 Cu copolymers was visualized in mice bearing human prostate cancer xenografts by positron emission tomography (PET) using a microPET scanner. …”
Get full text

A Case of Hydrocele Stone with Its Composition Analysis by Masayoshi Zaitsu, Koji Mikami, Yuta Takeshima, Takumi Takeuchi

“…We present here another case of hydrocele stone incidentally discovered when castration was being undergone for the endocrine treatment of prostate cancer. A 71-year-old man was diagnosed as stage D2 prostate cancer with his prostate-specific antigen 387 ng/ml. …”
Get full text

Symphysis Pubis Osteomyelitis: An Uncommon Complication after Robotic Assisted Radical Prostatectomy—Case Description with Literature Review by Jad A. Degheili, Mazen M. Mansour, Rami W. Nasr

“…Prostate cancer is the most common solid cancer among American men. …”
Get full text

Impact of finasteride on modulating the risk and clinical outcomes of bladder cancer: insights from a comprehensive meta-analysis by Ailing Yu, Ailing Yu, Ailing Yu, Ailing Yu, Ailing Yu, Zian Bai, Zian Bai, Zian Bai, Zian Bai, Yijie Wang, Yijie Wang, Yijie Wang, Yijie Wang, Zhen Luo, Zhen Luo, Zhen Luo, Zhen Luo, Xiaochen Du, Mengxin Chen, Shuang Wen, Honglong Wang, Xiaoying Yuan, Chunyu Yang, Shanshan Bai, Bo Fan, Bo Fan, Bo Fan, Bo Fan

Get full text

p53-loss induced prostatic epithelial cell plasticity and invasion is driven by a crosstalk with the tumor microenvironment by Darya Yanushko, Beatriz German Falcon, Rana El Bizri, Despoina Pervizou, Robin Dolgos, Céline Keime, Tao Ye, Christelle Thibault-Carpentier, Clementine Le Magnen, Sandrine Henri, Gilles Laverny, Daniel Metzger

“…Abstract Prostate cancer is a heterogeneous disease with a slow progression and a highly variable clinical outcome. …”
Get full text

Calcium Activation of the Androgen Receptor in Prostate Cells by Zeina W. Sharawi, Sawsan M. Khatrawi, Qiaochu Wang, Hongzhao Zhou, Kedra Cyrus, Gai Yan, Becky Hoxter, Bassem R. Haddad, Mary Beth Martin

“…Background. Although prostate cancer patients initially respond to androgen deprivation therapy, most patients progress to a resistant phenotype. …”
Get full text

Scrotal Skin Metastases Revealing a Prostatic Adenocarcinoma by Idriss Ziani, Zayd El Boukili El Makhoukh, Ahmed Ibrahimi, Omar Bellouki, Jihane Benahmed, Yasmine Laraqui, Fouad Zouidia, Hachem El Sayegh, Lounis Benslimane, Yassine Nouini

“…Introduction. Prostate cancer is the most common cancer in men. Cutaneous metastasis from prostate cancer is an unusual clinical finding. …”
Get full text

Penile Rehabilitation and Neuromodulation by Fernando Facio, Arthur L. Burnett

“…Erectile dysfunction (ED) following treatment for clinically localized prostate cancer, particularly radical prostatectomy (RP), is a major quality of life issue that remains unsatisfactorily addressed. …”
Get full text

Incontinence and Erectile Dysfunction Following Radical Prostatectomy: A Review by Gerasimos Alivizatos, Andreas Skolarikos

“…Radical prostatectomy remains the treatment of choice for localized prostate cancer in age-appropriate and health-appropriate men. …”
Get full text

A Case of Prostatic Carcinoma Manifesting as Cutaneous Facial Nodule by Israel Antonio Esquivel-Pinto, Bertha Torres-Alvarez, Ramiro Jetzabel Gómez-Villa, Juan Pablo Castanedo-Cázares

“…Prostate cancer is the second most frequently diagnosed cancer worldwide and the fifth most common cause of cancer deaths among men. …”
Get full text

Prostate-Specific Membrane Antigen-Based Therapeutics by Naveed H. Akhtar, Orrin Pail, Ankeeta Saran, Lauren Tyrell, Scott T. Tagawa

“…Prostate cancer (PC) is the most common noncutaneous malignancy affecting men in the US, leading to significant morbidity and mortality. …”
Get full text

Central Nervous System-related Conditions and Associated Healthcare Resource Use Among Japanese nmCRPC Patients Based on Retrospective Claims Data by Dianne A. Ledesma, Jonathan L. Chua, Susan S.H. Tang, Xiu W. Lim

“…**Background:** Japanese patients with prostate cancer are typically treated with primary androgen deprivation therapy (ADT), most commonly administered as a combination of a luteinizing hormone-releasing hormone (LHRH) agonist and an antiandrogen (AA). …”
Get full text

Cancer Incidence Among People With a Prior Hospital Record of Depression in Scotland, 1991–2019: A Cohort Study by Thulani Ashcroft, Kelly Fleetwood, Christine Campbell, Caroline A. Jackson

“…Depression was associated with higher risks of lung (RR 1.79, 95% CI 1.70–1.88) and colorectal cancer (RR 1.12, 95% CI 1.05–1.19), but not breast or prostate cancer. Conclusions We identified an entrenched disparity in cancer incidence by depression status. …”
Get full text

Economic Evaluation of Robotic-assisted Radical Prostatectomy: A Systematic Review and Meta-analysis by Tanan Bejrananda, Win Khaing, Sajesh K. Veettil, Therdpong Thongseiratch, Nathorn Chaiyakunapruk

“…The findings of this review can support decision-making for prostate cancer treatment options.…”
Get full text

The impact of specialised gastroenterology services for pelvic radiation disease (PRD): Results from the prospective multi-centre EAGLE study. by John N Staffurth, Stephanie Sivell, Elin Baddeley, Sam Ahmedzai, H Jervoise Andreyev, Susan Campbell, Damian J J Farnell, Catherine Ferguson, John Green, Ann Muls, Raymond O'Shea, Sara Pickett, Lesley Smith, Sophia Taylor, Annmarie Nelson

“…Men (n = 339) who had had radical radiotherapy for prostate cancer at least 6 months previously, were recruited; of which 91/339 were eligible to participate; 58/91 men (63.7%) accepted the referral. …”
Get full text